Height and bone mineral density in androgen insensitivity syndrome with mutations in the androgen receptor gene
- 1 November 2006
- journal article
- research article
- Published by Springer Nature in Osteoporosis International
- Vol. 18 (3) , 369-374
Abstract
Androgen insensitivity syndrome (AIS) constitutes a natural model to study effects of androgens and estrogens on growth and bone density. We evaluated height and bone density in patients with AIS with mutations in the androgen receptor (AR) gene.Keywords
This publication has 36 references indexed in Scilit:
- The ‘muscle-bone unit’ during the pubertal growth spurtBone, 2004
- Role of estrogen and androgen in pubertal skeletal physiologyMedical and Pediatric Oncology, 2003
- Puberty and bone developmentBest Practice & Research Clinical Endocrinology & Metabolism, 2002
- Progressive decrease in bone density over 10 years of androgen deprivation therapy in patients with prostate cancerUrology, 2001
- Differences in bone mineral in young Asian and Caucasian Americans may reflect differences in bone sizeJournal of Bone and Mineral Research, 1996
- Bone mass in androgen-insensitivity syndrome: Response to hormonal replacement therapyCalcified Tissue International, 1995
- New approaches for interpreting projected bone densitometry dataJournal of Bone and Mineral Research, 1992
- Pubertal growth in patients with androgen insensitivity: Indirect evidence for the importance of estrogens in pubertal growth of girlsThe Journal of Pediatrics, 1986
- Tentative Evidence of Y-linked Statural Gene(s)Clinical Pediatrics, 1985
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976